AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
North America Commercial Headquarters
1800 Concord Pike
P.O. Box 15437
Wilmington, DE 19850
+1 (302) 886-3000
RELATED ARTICLES
Researcher Profile: René van der Merwe
Biologics could bring an end to today’s “one size fits all” approach to treating asthma says René van der Merwe.
Innovation gave me back my ability to breathe
Gil shares his experience living with severe asthma, and the impact new treatments have on his life.
Researcher Profile: Roland Kolbeck
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory biologic treatment.
A New Era for Asthma Treatment
With more than 100 medicines for respiratory diseases currently in development and 49 medicines for asthma alone, the future has never been brighter.
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford innovation by reading the story of David Cobden, Ph.D., who works to pursue new payment models for a variety of cutting-edge treatments.
Improving Cancer Treatment by Studying DNA Damage Response
DNA damage response (DDR) is a term used to describe the network of cellular pathways that minimize the daily impact of DNA damage.
Searching for a Cure for Heart Failure
Researchers at AstraZeneca have focused extensive research and resources on developing a treatment that sounds like the stuff of science fiction – helping the heart repair itself.
POPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Understanding mRNA Vaccines
Scientists are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE